Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia

Clinical trial NCT07492875 · WITHDRAWN

Trial details

NCT number: NCT07492875
Sponsor: ImmunityBio, Inc.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Community-Acquired Pneumonia (CAP)Acute Respiratory Distress Syndrome (ARDS)Sepsis Lymphopenia Immunoparalysis

Start date: 2026-04-15
Primary completion: 2029-04-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.